General information
The pharmacist has dispensed ONTOZRY® (12.5mg/25mg, 50 mg, 100 mg, 150mg) doses to the patient. The health insurer will not reimburse the cost of this prescription in full. The…
FAQ by subject:
Payments Reimbursements
Why do I receive a different amount than I have entered?
You enter the amount of the personal contribution yourself when you submit a…
For what medicines is an invoice/pharmacy receipt required?
In case you make a claim for one of the following medicines you need an invoice/pharmacy receipt:
Forxiga® Jardiance® Xigudo®…
General information
The pharmacist has dispensed Zeposia® (0,23mg+0,46mg en 0,92mg) to the patient. The health insurer will not reimburse the cost of this prescription in full. The manufacturer of…
PATIENTS CAN ONLY CLAIM THEIR PAID CONTRIBUTION, NOT THEIR EXCESS
General information
The pharmacist has dispensed Isturisa® 1 mg, 5 mg or 10 mg to the patient. The health insurer will not…
Reimbursement Scheme Isturisa®
The health insurer does not fully reimburse Isturisa® 1mg, 5mg and 10mg. The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the…
Termination TerugBetaalRegeling Forxiga® - Chronic Kidney Disease
From May 1st 2022 onwards, Forxiga® (dapagliflozine) 10 mg for the treatment of chronic kidney disease (CKD) is fully reimbursed by…
Extension to TerugBetaalRegeling Elvanse®
The health insurer does not fully reimburse Elvanse® 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg. The manufacturer of this medicine has therefore…
Reimbursement Scheme Ontozry® (12.5mg/25mg, 50 mg, 100 mg, 150mg)
The health insurer does not fully reimburse ONTOZRY® (12.5mg/25mg, 50 mg, 100 mg, 150mg). The producer of this medicine has…
Reimbursement Scheme Jardiance® (empagliflozin)10 mg for patients with HFpEF (Ejection fraction>40%)
The health insurer does not yet fully reimburse Jardiance (Empagliflozin)® 10 mg for the…
